Vasodilating versus first-generation β-blockers for cardiovascular protection.
about
β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literatureA Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography.Different effects of selective β1-adrenoceptor antagonists, nebivolol or atenolol in acetaminophen-induced hepatotoxicity of rats.Insights on β-blockers for the treatment of hypertension: A survey of health care practitionersDevelopment of Lecithin Nanoemulsion Based Organogels for Permeation Enhancement of Metoprolol through Rat Skin
P2860
Vasodilating versus first-generation β-blockers for cardiovascular protection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@en
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@nl
type
label
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@en
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@nl
prefLabel
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@en
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@nl
P2093
P2860
P356
P1476
Vasodilating versus first-generation β-blockers for cardiovascular protection.
@en
P2093
Carl J Lavie
Hassan Fares
Hector O Ventura
P2860
P356
10.3810/PGM.2012.03.2532
P407
P577
2012-03-01T00:00:00Z